NPO enters the week on the front foot. Q1 earnings beat consensus, the stock added 4.2% over five days to close at $300.10, and Keybanc responded by raising its price target. The dominant story here is not short sellers — it is a company that is starting to be re-rated upward by the Street after a strong print.
The most direct catalyst is the analyst action. Keybanc lifted its target on NPO to $345 from $310 on May 6, maintaining its Overweight rating — a notable move given the stock had already cleared the prior target. The mean consensus target now stands at $327, implying roughly 9% upside from current levels. That gap would be modest if not for how aggressively targets have been chased higher: Keybanc has raised its target five times since August 2025, starting from $220. Oppenheimer is directionally aligned, holding an Outperform with a $285 target — now well below current trading. The EPS momentum scores support the bullish framing, with 30-day EPS momentum ranking in the 76th percentile and the 12-month forward EPS year-on-year growth estimate sitting in the 86th percentile. That is a company whose earnings trajectory is improving faster than most of its peer group.
The Q1 print itself adds context. Enpro beat estimates by $0.06 per share, and the 10-Q for the March quarter was filed on May 5. The next event is Q2 results, scheduled for August 4. The PE multiple has expanded alongside the price — it now stands near 31.5x, up roughly 4 points over the past month — while EV/EBITDA has climbed to 21x. Neither is cheap for an industrial machinery name, but the market is paying for the growth narrative, not current earnings. The RSI at 64 is elevated without being extreme, consistent with a stock trending rather than overheating.
Short interest plays no meaningful role in the current setup. At 1.7% of the free float, the borrowed position is small. The week-on-week move of around 7% is a tick higher, but with borrow availability abundant and days to cover below two, there is no squeeze dynamic and no short-side pressure worth highlighting. The ORTEX short score of 29.6 is low — comfortably in the bottom third of the universe — and has barely moved in recent sessions. Cost to borrow at 0.47% annual is negligible. Options positioning has actually turned less defensive over the past fortnight: the put/call ratio has dropped from a 52-week high of 2.58 in mid-April to 1.18 now, nearly one standard deviation below its 20-day average of 1.67. Whatever hedging was in place ahead of the earnings print has largely been unwound.
On the ownership side, the largest holder is BlackRock at roughly 14.8% of shares, with Vanguard at 10.7% — passive concentration that is typical for a $6bn industrial. The more interesting footnote is that FMR added approximately 195,000 shares in the February period, a meaningful addition for a name this size. Insider activity through early March was entirely on the sell side, with the Chief Administration Officer and an independent director accounting for most of the volume. Those sales came at prices between $265 and $278 — well below where the stock is trading now, which softens any negative read on those disposals.
The next test for NPO is the August earnings call. By then, the Street will be watching whether the EPS momentum that drove successive target upgrades continues to translate into actual beats, or whether the expanded PE multiple leaves the stock exposed if the growth narrative wavers.
See the live data behind this article on ORTEX.
Open NPO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
